We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 25th Jul 2014 09:29

African Barrick Gold: Investec places both its target price (prev.: 212p) and its sell recommendation under review. Westhouse Securities ups target price from 250p to 285p upgrading from neutral to add.Barclays: Deutsche Bank cuts target price from 300p to 275p staying with its buy recommendation.Barr AG: Investec ups target price from 645p to 661p retaining an add rating.Bodycote: Berenberg ups target price from 759p to 776p upgrading from hold to buy.BSkyB: Westhouse Securities places both its target price (prev.: 985p) and its neutral rating under review. Investec places its target price (prev.: 825p) and its reduce rating under review.bwin.party: Credit Suisse lowers target price from 99p to 88p and reiterates an underperform rating.CSR: Deutsche Bank raises target price from 400p to 420p and maintains a buy recommendation.De La Rue: Numis upgrades from hold to add with a target price of 845p.Drax Group: Societe Generale cuts target price from 680p to 630p downgrading to sell.easyJet: UBS reduces target price from 2100p to 1930p and keeps a buy recommendation.Electrocomponents: Jefferies cuts target price from 250p to 230p leaving its hold recommendation unchanged. Deutsche Bank cuts target price from 290p to 265p and retains a hold recommendation. Canaccord Genuity cuts target price from 356p to 313p retaining a buy recommendation. Credit Suisse cuts target price from 260p to 220p and stays with its underperform rating.GlaxoSmithKline: UBS reduces target price from 1500p to 1380p downgrading from neutral to sell.Howden Joinery: Canaccord Genuity raises target price from 305p to 410p and maintains a buy recommendation.InterContinental Hotels Group: Nomura raises target price from 2065p to 2365p staying with its neutral rating.Interserve: Berenberg initiates with a target price of 750p and a buy recommendation.Kingfisher: Deutsche Bank cuts target price from 460p to 430p and stays with its buy recommendation. Societe Generale cuts target price from 353p to 320p and skeeps a hold recommendation-Lancashire Holdings: Deutsche Bank cuts target price from 762p to 724p and maintains a buy recommendation. Canaccord Genuity cuts target price from 690p to 670p and retains a hold recommendation.Lonmin: Investec places both its target price(prev.: 238p) and its sell recommendation under review.Marston's: Beaufort upgrades to buy.Mitchells & Butlers: Beaufort initiates with a buy recommendation.Petrofac: Societe Generale reduces target price from 1480p to 1220p downgrading to hold.Provident Financial: Societe Generale increases target price from 1560p to 2270p and reiterates a hold recommendation.Rathbone Brothers: Numis ups target price from 1825p to 1860p and reiterates a hold recommendation.Reckitt Benckiser: Jefferies raises target price from 4500p to 5000p and keeps a hold recommendation.Reed Elsevier: Nomura ups target price from 1050p to 1080p maintaining a buy recommendation. Morgan Stanley takes target price from 1000p to 1030p retaining an overweight rating. Numis raises target price from 1031p to 1130p staying with an add rating.Rexam: Jefferies downgrades from buy to hold with a target price of 550p.Ricardo: Berenberg initiates with a target price of 735p and retains a buy recommendation.Spectris: Numis downgrades from add to hold with a target price of 2300p. Investec places both its target price (prev.: 2720p) and its buy recommendation under review.Stagecoach: Nomura moves target price from 390p to 400p staying with its buy recommendation.Tate & Lyle: UBS lowers target price from 630p to 615p and reiterates a sell recommendation. Canaccord Genuity cuts target price from 660p to 640p and stays with its hold recommendation. Credit Suisse cuts target price from 540p to 630p leaving its underperform rating unaltered.Topps Tiles: Berenberg initiates with a target price of 170p and a buy recommendation.
More News
Today 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.